Bradycardia sinus

Arrhythmias Originating in the Sinus Node Sinus bradycardia Sick sinus syndrome Sinus tachycardia Disorders of Impulseformation ... 

Cardiac glycosides have a small ratio of toxic to therapeutic concentration. Possible adverse effects are nausea, vomiting, abdominal pain, diarrhoea, fatigue, headache, drowsiness, colour vision disturbances, sinus bradycardia, premature ventricular complexes, AV-block, bigeminy, atrial tachycardia with AV-Block, ventricular fibrillation. There are several mechanisms relevant for their toxic action (Table 2). 

These drags are contraindicated in patients with an allergy to the (3 blockers, in patients with sinus bradycardia, second- or third-degree heart block, heart failure, and those with asthma, emphysema, or hypotension. The drug are used cautiously in patients with diabetes, thyrotoxicosis, and peptic ulcer. 

The hydantoins are contraindicated in patients widi known hypersensitivity to die drug s. Phenytoin is contraindicated in patients widi sinus bradycardia, sinoatrial block, second and diird degree AV block, and Adams-Stokes syndrome it also is contraindicated during pregnancy (ediotoin and phenytoin are Pregnancy Category D) and lactation. Ediotoin is contraindicated in patients widi hepatic abnormalities. 

Compare and contrast the risk factors for and the features, mechanisms, etiologies, symptoms, and goals of therapy of (1) sinus bradycardia (2) atrioventricular (AV) nodal blockade (3) atrial fibrillation (AF) (4) paroxysmal supraventricular tachycardia (PSVT) ... 

Compare and contrast appropriate nonpharmacologic and pharmacologic treatment options for sinus bradycardia and AV nodal blockade. 

Design individualized drug therapy treatment plans for patients with (1) sinus bradycardia (2) AV nodal blockade (3) AF (4) PSVT (5) VPDs (6) VT (including torsades de pointes) and (7) VF. 

Sinus bradycardia is an arrhythmia that originates in the SA node, defined by a sinus rate less than 60 beats per minute (bpm).12... 

Many individuals, particularly those who partake in regular vigorous exercise, have heart rates less than 60 bpm. For those individuals, sinus bradycardia is normal and healthy, and does not require evaluation or treatment. However, some individuals develop symptomatic sinus node dysfunction. In the absence of correctable underlying causes, idiopathic sinus node dysfunction is referred to as sick sinus syndrome,12 and occurs with greater frequency with advancing age. The prevalence of sick sinus syndrome is approximately 1 in 600 individuals over the age of 65 years.12... 

Sick sinus syndrome leading to sinus bradycardia may be caused by degenerative changes in the sinus node that occur with advancing age. However, there are other possible etiologies of sinus bradycardia, including drugs (Table 6-2).13... 

History of present illness, presenting symptoms, and 12-lead ECG that reveals sinus bradycardia. 

Determine whether the patient is taking any drugs known to cause sinus bradycardia. If the patient is currently taking digoxin, determine the serum digoxin concentration and ascertain whether it is supratherapeutic (greater than 2 ng/mL [2.56 nmol/L]). 

Sick sinus syndrome leading to sinus bradycardia occurs as a result of fibrotic tissue in the SA node, which replaces normal SA node tissue.12... 

In patients with sinus bradycardia due to underlying correctable disorders (such as electrolyte abnormalities or hypothyroidism), management consists of correcting those disorders. 

Treatment of sinus bradycardia is only necessary in patients who become symptomatic. If the patient is taking any med-ication(s) that may cause sinus bradycardia, the drug(s) should be discontinued whenever possible. If the patient remains in sinus bradycardia after discontinuation of the drug(s) and after five half-lives of the drug(s) have elapsed, then the drugs(s) can usually be excluded as the etiology of the arrhythmia. In certain circumstances, however, discontinuation of the medication(s) may be undesirable, even if it may be the cause of symptomatic sinus bradycardia. For example, if the patient has a history of myocardial infarction or HF, discontinuation of a (3-blocker is undesirable, because (3-blockers have been shown to reduce mortality and prolong life in patients with those diseases, and the benefits of therapy with... 

Acute treatment of patients with second- or third-degree AV nodal blockade consists primarily of administration of atropine, which maybe administered in the same doses as recommended for management of sinus bradycardia. In patients with hemodynamically unstable or severely symptomatic AV nodal blockade that is unresponsive to atropine and in whom temporary or transvenous pacing is not available or is ineffective, epinephrine (2 to 10 mcg/minute, titrate to response) and/or dopamine (2 to 10 mcg/kg/minute) maybe administered.14... 

Adenosine Chest pain, flushing, shortness of breath, sinus bradycardia/AV block... 

Amiodarone IV Hypotension, sinus bradycardia Oral Blue-grey skin discoloration, photosensitivity, corneal microdeposits, pulmonary fibrosis, hepatotoxicity, sinus bradycardia, hypo- or hyperthyroidism, AV block... 

Diltiazem Hypotension, sinus bradycardia, heart failure exacerbation, AV block... 

Sotalol Sinus bradycardia, AV block, fatigue, torsades de pointes... 

Sick sinus syndrome Idiopathic sinus node dysfunction leading to symptomatic sinus bradycardia. 

Blockers are contraindicated in patients with decompensated heart failure unless it is caused solely by tachycardia (high output). Other contraindications include sinus bradycardia, concomitant therapy with monoamine oxidase inhibitors or tricyclic antidepressants, and patients with spontaneous hypoglycemia. Side effects include nausea, vomiting, anxiety, insomnia, lightheadedness, bradycardia, and hematologic disturbances. 

It opens a ion channel in the sinoatrial node, which slows the initiation of the electric signals that control the heartbeat (this is known as sinus bradycardia). 

Signs of intoxication are (1) cardiac arrhythmias, which under certain circumstances are life-threatening, e.g., sinus bradycardia, AV-block, ventricular extrasystoles, ventricular fibrillation (ECG) (2) CNS disturbances — altered color vision (xanthopsia), agitation, confusion, nightmares, hallucinations (3) gastrointestinal — anorexia, nausea, vomiting, diarrhea (4) renal — loss of electrolytes and water, which must be differentiated from mobilization of accumulated edema fluid that occurs with therapeutic dosage. 

Sinus bradycardia. An abnormally low sinoatrial impulse rate (<60/min) can be raised by parasympatholytics. The quaternary ipratropium is preferable to atropine, because it lacks CNS penetrability (p. 107). Sympathomimet-ics also exert a positive chronotropic action they have the disadvantage of increasing myocardial excitability (and automaticity) and, thus, promoting ectopic impulse generation (tendency to extrasystolic beats). In cardiac arrest epinephrine can be used to reinitiate heart beat... 

A cohort of gasoline depot workers exposed to a mean external TEL concentration of 84.8 pg/m (as Pb) had a statistically increased frequency of appearance of tremor and sinus bradycardia (vs. controls). No clinical neurological or neurobehavioral findings were found after long-term exposure at a chemical manufacmring plant where TEL exposures ranged from 0.6 to 43.1 pg/m (as Pb). ... 

Sinus node disease andAVbiock The drug may cause severe sinus bradycardia or sinoatrial block in patients with preexisting sinus node disease and may cause advanced or complete heart block in patients with preexisting incomplete AV block. Consider inserting a pacemaker before treatment with digoxin. 

---